SURVIVAL BENEFIT FROM 5 FLUOROURACIL-BASED ADJUVANT CHEMOTHERAPY IN PATIENTS WITH ASTLER-COLLER STAGE B2, P21/WAF1 POSITIVE COLORECTAL CANCER

(1) Oncology

(2) Genetics and Pathology

(3) Pathology

(4) Gastroenterology and Internal Medicine

(5) Biochemistry and Medical Chemistry, Pomeranian Medical University, Szczecin, Poland



This item was part of the Treatment and biomarkers for colorectal cancer session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A51